Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells.

J Exp Med · 2020 · PMC7336313 · PMID 32374402

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

showed a trendno p-value reported

We found that inactivation of Prdm1 in Hdac3- KO CD8 T cells showed a trend toward improved persistence compared with Hdac3- WT CD8 T cells, but this effect did not reach statistical significance in all experiments (pooled data shown in Fig. 7 C ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.